BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a ...

In May 2013, during his first run as the CEO of Bausch and Lomb, he orchestrated its $8.7 billion sale to Valeant ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

CHATHAM, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of ...

As per data from GlobalData’s Pharmaceutical Intelligence Centre, the highest number of deals made in radiopharmaceuticals space for the past decade took place in 2024. Pio argues that this trend is ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Both facilities specialise in viral vector development and manufacturing. A Thermo Fisher spokesperson told Pharmaceutical Technology: “In light of recent shifts in customer timelines and utilisation ...